TABLE OF CONTENTS
Volume 17, Issue 5 (May 2003)
Commentary |
Review |
Molecular Targets for Therapy (MTT) |
Keynote Address |
Original Manuscripts |
Spotlight Correspondence |
Correspondence |
Book Review
Spotlight
Successful peripheral blood stem cell mobilisation with filgrastim in patients with chronic myeloid leukaemia achieving complete cytogenetic response with imatinib, without increasing disease burden as measured by quantitative real-time PCR FREE
C H Hui, K Y Goh, D White, S Branford, A Grigg, J F Seymour, Y L Kwan, S Walsh, R Hoyt, A Trickett, B Rudzki, D D F Ma, L B To and T P Hughes
Leukemia 17: 821-828; doi:10.1038/sj.leu.2402917
Resistance of Philadelphia-chromosome positive leukemia towards the kinase inhibitor imatinib (STI571, Glivec): a targeted oncoprotein strikes back FREE
N von Bubnoff, C Peschel and J Duyster
Leukemia 17: 829-838; doi:10.1038/sj.leu.2402889
Commentary
Prognostic implications of epigenetic silencing of p15INK4B in acute promyelocytic leukemia FREE
Guillermo Garcia-Manero
Leukemia 17: 839-840; doi:10.1038/sj.leu.2402908
Review
Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning FREE
P Dreger, R Brand, J Hansz, D Milligan, P Corradini, J Finke, G L Deliliers, R Martino, N Russell, A van Biezen, M Michallet and D Niederwieser on behalf of the Chronic Leukemia Working Party of the EBMT
Leukemia 17: 841-848; doi:10.1038/sj.leu.2402905
Molecular Targets for Therapy (MTT)
In vitro antiproliferative activity of the farnesyltransferase inhibitor R115777 in hematopoietic progenitors from patients with myelofibrosis with myeloid metaplasia FREE
R A Mesa, A Tefferi, L A Gray, T Reeder, G Schroeder and S H Kaufmann
Leukemia 17: 849-855; doi:10.1038/sj.leu.2402901
Keynote Address
Bone marrow transplantation: how important is CD34 cell dose in HLA-identical stem cell transplantation? FREE
S Heimfeld
Leukemia 17: 856-858; doi:10.1038/sj.leu.2402893
Original Manuscripts
The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921) FREE
M Oosterveld, S Suciu, G Verhoef, B Labar, A Belhabri, C Aul, D Selleslag, A Ferrant, P Wijermans, F Mandelli, S Amadori, U Jehn, P Muus, R Zittoun, U Hess, Ö Anak, F Beeldens, R Willemze and T de Witte
Leukemia 17: 859-868; doi:10.1038/sj.leu.2402897
Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation FREE
M Mohty, K Bilger, E Jourdan, M Kuentz, M Michallet, J H Bourhis, N Milpied, L Sutton, J P Jouet, M Attal, P Bordigoni, J Y Cahn, A Sadoun, N Ifrah, D Guyotat, C Faucher, N Fegueux, J Reiffers, D Maraninchi and D Blaise
Leukemia 17: 869-875; doi:10.1038/sj.leu.2402909
Cryptic insertion and translocation or nondividing leukemic cells disclosed by FISH analysis in infant acute leukemia with discrepant molecular and cytogenetic findings FREE
N Watanabe, H Kobayashi, O Ichiji, M A Yoshida, A Kikuta, Y Komada, I Sekine, Y Ishida, Y Horiukoshi, Y Tsunematsu, M Yano, H Nakadate and Y Kaneko
Leukemia 17: 876-882; doi:10.1038/sj.leu.2402900
FLT3-TKD mutation in childhood acute myeloid leukemia FREE
D-C Liang, L-Y Shih, I-J Hung, C-P Yang, S-H Chen, T-H Jaing, H-C Liu, L-Y Wang and W-H Chang
Leukemia 17: 883-886; doi:10.1038/sj.leu.2402928
Expression of HOX11 in childhood T-lineage acute lymphoblastic leukaemia can occur in the absence of cytogenetic aberration at 10q24: a study from the Children's Cancer Group (CCG) FREE
U R Kees, N A Heerema, R Kumar, P M Watt, D L Baker, M K La, F M Uckun and H N Sather
Leukemia 17: 887-893; doi:10.1038/sj.leu.2402892
Dendritic cells loaded with apoptotic tumour cells induce a stronger T-cell response than dendritic cell–tumour hybrids in B-CLL FREE
P Kokhaei, M R Rezvany, L Virving, A Choudhury, H Rabbani, A Österborg and H Mellstedt
Leukemia 17: 894-899; doi:10.1038/sj.leu.2402913
Efficient elimination of chronic lymphocytic leukaemia B cells by autologous T cells with a bispecific anti-CD19/anti-CD3 single-chain antibody construct FREE
A Löffler, M Gruen, C Wuchter, F Schriever, P Kufer, T Dreier, F Hanakam, P A Baeuerle, K Bommert, L Karawajew, B Dörken and R C Bargou
Leukemia 17: 900-909; doi:10.1038/sj.leu.2402890
Aberrant methylation and impaired expression of the p15 INK4b cell cycle regulatory gene in chronic myelomonocytic leukemia (CMML) FREE
M Tessema, F Länger, J Dingemann, A Ganser, H Kreipe and U Lehmann
Leukemia 17: 910-918; doi:10.1038/sj.leu.2402891
Hypermethylation of GpG islands in the promoter region of p15INK4b in acute promyelocytic leukemia represses p15INK4b expression and correlates with poor prognosis FREE
L Teofili, M Martini, M Luongo, D Diverio, G Capelli, M Breccia, F Lo Coco, G Leone and L M Larocca
Leukemia 17: 919-924; doi:10.1038/sj.leu.2402907
Infectious complications in patients with acute promyelocytic leukaemia treated with the AIDA regimen FREE
C Girmenia, F Lo Coco, M Breccia, R Latagliata, A Spadea, M D'Andrea, G Gentile, A Micozzi, G Alimena, P Martino and F Mandelli
Leukemia 17: 925-930; doi:10.1038/sj.leu.2402899
Glutathione depletion overcomes resistance to arsenic trioxide in arsenic-resistant cell lines FREE
K Davison, S Côté, S Mader and W H Miller Jr
Leukemia 17: 931-940; doi:10.1038/sj.leu.2402876
Hematopoietic stem cell transplantation for hematological malignancies in Europe FREE
A Gratwohl, H Baldomero, J Passweg, F Frassoni, D Niederwieser, N Schmitz and A Urbano-Ispizua for the Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT) in cooperation with the Working Parties Acute (ALWP) and Chronic Leukemias (CLWP) and the Lymphoma Working Party
Leukemia 17: 941-959; doi:10.1038/sj.leu.2402896
Human cord blood long-term engrafting cells are CD34+ CD38- FREE
F Ishikawa, A G Livingston, H Minamiguchi, J R Wingard and M Ogawa
Leukemia 17: 960-964; doi:10.1038/sj.leu.2402878
An isoform of the Wilms' tumor suppressor gene potentiates granulocytic differentiation FREE
D M Loeb, J L Summers, E A Burwell, D Korz, A D Friedman and S Sukumar
Leukemia 17: 965-971; doi:10.1038/sj.leu.2402906
Prognostic value of GST-
expression in diffuse large B-cell lymphomas FREE
V Ribrag, S Koscielny, I Carpiuc, C Cebotaru, H Vande Walle, M Talbot, P Fenaux and J Bosq
Leukemia 17: 972-977; doi:10.1038/sj.leu.2402930
Spotlight Correspondence
Histological features of acute hepatitis after imatinib mesylate treatment FREE
C James, H Trouette, G Marit, P Cony-Makhoul and F-X Mahon
Leukemia 17: 978-979; doi:10.1038/sj.leu.2402910
Correspondence
MLL partial tandem duplications in acute leukemia cell lines FREE
H Quentmeier, J Reinhardt, M Zaborski and H G Drexler
Leukemia 17: 980-981; doi:10.1038/sj.leu.2402911
Genotypes of the glutathione S-transferase superfamily do not correlate with outcome of childhood acute lymphoblastic leukemia FREE
Alessandra Sala, Marina Lanciotti, Maria Grazia Valsecchi, Paola di Michele, Carlo Dufour, Riccardo Haupt, Giuseppe Basso, Carmelo Rizzari and Andrea Biondi
Leukemia 17: 981-983; doi:10.1038/sj.leu.2402888
Interferon-
modulates the immune response enhancing B7-1 and B7-2 costimulatory molecules and T8 lymphocytes in chronic myeloid leukemia FREE
C Delfini, F Centis, L Tabellini, G Nicolini and G Visani
Leukemia 17: 983-984; doi:10.1038/sj.leu.2402903
Reply to letter from C Delfini et al FREE
R L Paquette
Leukemia 17: 985; doi:10.1038/sj.leu.2402902
A case of acute promyelocytic leukaemia following mitoxantrone treatment of multiple sclerosis FREE
C Cattaneo, C Almici, E Borlenghi, M Motta and G Rossi
Leukemia 17: 985-986; doi:10.1038/sj.leu.2402887
Microdose -interferon shows clinical and antiangiogenic effect in extramedullary myeloid tumor: a case report FREE
P P Piccaluga, G Visani, A Isidori, M Malagola, S Ascani and S A Pileri
Leukemia 17: 986-987; doi:10.1038/sj.leu.2402904
Serum levels of the nm23-H1 protein and their clinical implication in extranodal NK/T-cell lymphoma FREE
N Niitsu, M Okamoto, Y Honma, H Nakamine, J-I Tamaru, S Nakamura, T Yoshino, M Higashihara, M Hirano and J Okabe-Kado Adult Lymphoma Treatment Study Group (ALTSG), Japan
Leukemia 17: 987-990; doi:10.1038/sj.leu.2402858
Comparison of fludarabine-containing salvage chemotherapy regimens for relapsed/refractory acute myelogenous leukemia FREE
M B Thomas, C Koller, Y Yang, Y Shen, S O'Brien, H Kantarjian, J Davis and E Estey
Leukemia 17: 990-993; doi:10.1038/sj.leu.2402862
A unique variant of ETV6/AML1 fusion in a child with acute lymphoblastic leukemia FREE
G R Jalali, M Martineau, A M Ford, M Greaves, R F Stevens and C J Harrison
Leukemia 17: 993-995; doi:10.1038/sj.leu.2402873
Constitutive phosphorylation of Akt/PKB protein in acute myeloid leukemia: its significance as a prognostic variable FREE
Y H Min, J I Eom, J W Cheong, H O Maeng, J Y Kim, H K Jeung, S T Lee, M H Lee, J S Hahn and Y W Ko
Leukemia 17: 995-997; doi:10.1038/sj.leu.2402874
